Hepatitis Associated Aplastic Anemia: A Review
Author Information
Author(s): Rauff Bisma, Idrees Muhammad, Shah Shahida Amjad Riaz, Butt Sadia, Butt Azeem M, Ali Liaqat, Hussain Abrar, Irshad-ur-Rehman, Ali Muhammad
Primary Institution: Division of Molecular Biology, National Centre of Excellence in Molecular Biology (CEMB), University of the Punjab
Hypothesis
Hepatitis-associated aplastic anemia (HAAA) is proposed to be attributed to various hepatitis and non-hepatitis viruses.
Conclusion
HAAA is a well-documented syndrome where an acute attack of hepatitis leads to marrow failure and pancytopenia, predominantly affecting children and young males.
Supporting Evidence
- HAAA occurs most frequently in young male children and is lethal if left untreated.
- Several hepatitis viruses such as HAV, HBV, HCV, HDV, HEV, and HGV have been associated with HAAA.
- Immunosuppressive therapy has shown effective responses in treating HAAA.
- The mortality rate for untreated HAAA can reach up to 85%.
Takeaway
HAAA is a serious condition that can happen after hepatitis, causing a lack of blood cells, and it needs to be treated quickly to avoid severe problems.
Methodology
The review discusses the clinical features, diagnosis, and treatment of HAAA based on existing literature.
Limitations
The review may not cover all recent studies or cases, and the data may be limited to specific populations.
Participant Demographics
HAAA predominantly occurs in children, adolescent boys, and young men.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website